Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
List view / Grid view
News
Paul Royall joins European Pharmaceutical Review
Dr Paul Royall, Senior Lecturer in Pharmaceutics at King’s College London, and Programme Director of the MSc in Pharmaceutical Analysis and Quality Control, has joined European Pharmaceutical Review's Editorial Advisory Board.
Merck joins forces to pioneer global oncology big data initiative
Merck has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, for oncology innovations...
Tecan introduces new solution for walkaway LC-MS sample prep
Tecan has unveiled its latest innovation, the automated RESOLVEX™ A200 positive pressure workstation for LC-MS sample prep...
Taselisib boosts breast tumour shrinkage
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...
Prestigious scientific organisations support Lab Innovations
Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – continues to garner support from across the scientific community...
Ingenza invests in faster fermentation development
Leading industrial biotechnology company Ingenza has acquired a high performance benchtop bioreactor system to enable faster development of new fermentation processes...
NewAge® Industries Achieves Landfill-Free Status
All waste is recycled or used in energy recovery systems...
Nivolumab cuts relapse by one third compared to Ipilimumab
Alternative immunotherapy drug nivolumab is more effective than current standard of care in treating advanced melanoma after surgical removal of disease.
FDA grants Breakthrough designation to Cemiplimab for CSCC
Cemiplimab receives FDA Breakthrough Therapy Designation for advanced cutaneous squamous cell carcinoma...
Pembrolizumab shows promise in pretreated metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
New method for producing malaria treatment at large scales
New research demonstrates that the malaria treatment, artemisinin can now be rapidly produced by genetically engineered moss at an industrial scale...
CBD may protect against psychiatric risk from high-THC cannabis strains
Neuroscientists have found that cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC...
Improved vaccine protects against nine types of HPV
Scientists have developed an improved vaccine commonly associated with cervical cancer...
Biotech hub outsources R&D to marketplace provider
LabCentral signs outsourced R&D provider Science Exchange, enabling access to more than 2,500 qualified scientific service providers
